TY - JOUR
AU - Schmidli, Robert 
TI - PCSK9 inhibitors – clinical applications
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2016
ET - 2016/10/01
VL - 39
IS - 5
SP - 168
EP - 170
DO - 10.18773/austprescr.2016.061
LA - eng
UR - https://australianprescriber.tg.org.au/articles/pcsk9-inhibitors-clinical-applications.html
KW - alirocumab
KW - bococizumab
KW - evolocumab
KW - ischaemic heart disease
KW - LDL cholesterol
KW - proprotein convertase subtilisin/kexin type 9
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -